Author:
Kojima Yoshiyuki,Sasaki Shoichi,Imura Makoto,Kubota Yasue,Hayashi Yutaro,Kohri Kenjiro
Funder
Scientific Fund of the Japan Health Science Foundation
Japanese Ministry of Education, Culture, Science and Technology
Japanese Foundation for Prostate Research
Naito Foundation
Japan Research Foundation for Clinical Pharmacology
Ichihara International Scholarship Foundation
Suzuken Memorial Foundation
Subject
Urology,Clinical Neurology
Reference26 articles.
1. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group;Narayan;J Urol,1998
2. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: Placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group;Lepor;Urology,1998
3. Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group;Chapple;Eur Urol,1996
4. Efficacy of alpha-adrenergic receptor blockers in the treatment of male lower urinary tract symptoms;Roehborn;Rev Urol,2009
5. Nocturia: Etiology, diagnosis, and treatment;Appell;Neurourol Urodyn,2008
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献